Medical Device

- High school students who complete Abbott's award-winning summer internship program are now eligible to receive college credit for the experience in a first-of-its-kind effort that can serve as a model for other companies to support STEM education.

Anushka Agashe, 18, high school STEM intern, Abbott.

Abbott's program, which has provided diverse teenagers across the U.S. with opportunities in the STEM fields for nearly a decade, is the first high school STEM internship that the American Council on Education (ACE) has recommended for college credit. Students who complete the program the summer after their senior year in high school are eligible to apply for up to two hours of credit from their educational institutions.

This important step is a continuation of Abbott's commitment to providing experience in the science, technology, engineering and math, or STEM, fields that leads to successful careers for young women and students from underrepresented groups. More than 60% of the students who have participated in the internship since it started in 2012 have come from diverse backgrounds.

Abbott's efforts include an updated edition of our "Shaping the Future of STEM" blueprint , which now has a chapter on how other companies can pursue college credit for their programs in addition to starting their own high school STEM internships. Abbott's high school interns complete meaningful, quality STEM-related work during their summers, including in areas like research and development, manufacturing, quality and regulatory, and operations.

"This innovative effort supports students as they earn their degrees and pursue STEM careers," said Mary Moreland , executive vice president, Human Resources, Abbott. "It will truly be a positive change in students' lives. Our goal is to help more students – particularly women and people from underrepresented groups – become STEM professionals."

The recommendation from the American Council on Education, the major coordinating body for U.S. higher education institutions, validates the quality of Abbott's program and enables attainment of educational and career goals for participants.

"ACE's Learning Evaluations program seeks to empower learners and improve economic mobility by validating learning experiences in post-traditional settings. Abbott's program can serve as a model, showcasing a commitment to quality training and preparation of learners for real-world applications. This supports our philosophy that what a person learns is more important than when and where the learning occurs," said Michele Spires , executive director for Learning Evaluations at ACE.

Real Experience, Real Lives
Abbott recruits interns starting as sophomores from specific high schools located near its facilities that meet certain criteria, including student populations with racial, ethnic and/or income diversity. One of those partners is Roseville Area High School in Roseville, Minn. , where Principal Christina Hester has seen the benefits of Abbott's STEM internship firsthand. The opportunity for students to earn credit while obtaining career experience only makes them higher-quality candidates when they apply to colleges, she said.

"You can't buy this kind of experience anywhere," Hester said. "Without a doubt this program and the college credit will make a difference for our students, and the skills they gain will make them marketable and valuable as future employees."

Graduating senior Anushka Agashe , 18, who will be attending the University of Illinois Urbana-Champaign this fall to major in bioengineering, said she will gain a head start toward earning her degree by completing her internship this August, her third summer with Abbott.

"Abbott's high school internship is giving me a double advantage," Agashe said. "First, the possibility of receiving college credit relieves financial burden. It's tuition I won't have to pay. That's on top of the real-life, hands-on experience I'm getting while working with professional engineers. My career path is much clearer now."

Shaping the Future of STEM
The U.S. alone will need another nearly 800,000 STEM workers by 2029. As part of Abbott's 2030 Sustainability Plan , the company intends to build on its efforts to decrease the STEM skills gap by creating opportunities for more than 100,000 young people, including 50% from underrepresented groups, to participate in Abbott's STEM programs and internships by 2030.

The high school internship has become a proven STEM talent pipeline for Abbott, guiding students through high school to Abbott's college internship program to full-time Abbott employee. Abbott has started hiring its first former high school interns as full-time engineers: 73% are women.

"If we want to live in a world where everyone benefits from the next great breakthroughs, we have to solve the STEM gender gap," said Sabina Ewing , vice president, Business and Technology Services, and chief information officer, Abbott. "Offering high school girls STEM internships helps them see a world they couldn't before: BIPOC, women engineers, scientists and IT professionals solving tangible problems — like creating an app for COVID testing. When they work alongside people who look like them at such a critical age, they are inspired to pursue STEM in college and beyond."

This success inspired Abbott to ask other companies to join in offering STEM experience to younger generations. To help, in 2019 Abbott released a blueprint containing detailed, scalable plans to recreate its high school internship program with the hope that other companies will use it to create similar programs and reach more students.

Download the second edition of our "Shaping the Future of STEM" blueprint at .

About the American Council on Education:
ACE is a membership organization that mobilizes the higher education community to shape effective public policy and foster innovative, high-quality practice. As the major coordinating body for the nation's colleges and universities, our strength lies in our diverse membership of more than 1,700 colleges and universities, related associations, and other organizations in America and abroad. ACE is the only major higher education association to represent all types of U.S. accredited, degree-granting institutions: two-year and four-year, public and private. For more information, please visit or follow ACE on Twitter @ACEducation .

About Abbott:
Abbott (NYSE: ABT) is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 109,000 colleagues serve people in more than 160 countries.

Connect with us at , on LinkedIn at , on Facebook at and on Twitter @AbbottNews .

Abbott Logo (PRNewsFoto/Abbott)

Cision View original content to download multimedia:


News Provided by PR Newswire via QuoteMedia

Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 20 th Annual Global Healthcare Conference on Wednesday, September 14 th , at the Sheraton New York Hotel in New York. Joaquin Duato, Chief Executive Officer, and Joseph J. Wolk, Executive Vice President and Chief Financial Officer will represent the Company in a session scheduled at 11:10 a.m. (Eastern Time).

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at .

News Provided by Business Wire via QuoteMedia

Keep reading...Show less


  • Revenues of $1.967 billion
  • Company to appeal anticipated court decision and vigorously defend XIFAXAN intellectual property
  • Balance sheet continues to improve with early retirement of $481 million of long-term debt through open market repurchases
  • Committed to strategic alternatives and will continue to evaluate the distribution of Bausch + Lomb shares as the Company works through patent litigation
  • Updates guidance

Bausch Health Companies Inc. (NYSETSX: BHC) ("Bausch Health" or the "Company" or "we" or "our") today announced its second-quarter 2022 financial results.

"The second quarter was a transitional quarter for Bausch Health as we intensified our focus on the Bausch Pharma and Solta businesses," Thomas J. Appio , Chief Executive Officer, Bausch Health , said. "In our first ninety days, our leadership team has taken immediate action to strengthen execution and accelerate change. We have advanced debt paydown through open market repurchases this quarter. We are focused on creating value through driving growth, profitability and improving our balance sheet."

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

Mathai Mammen, M.D., Ph.D., Leaves Position as Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson

Johnson & Johnson (NYSE: JNJ) ("the Company") announced today that Mathai Mammen, M.D., Ph.D., has decided to leave his position as Executive Vice President, Pharmaceuticals, R&D, and pursue other opportunities outside of the Company. William Hait, M.D., Ph.D., will serve as interim head of the Pharmaceutical R&D organization until new leadership is identified.

Dr. Mammen joined Johnson & Johnson in 2017 as Global Head of Janssen R&D, and the Company thanks Dr. Mammen for his contributions in advancing Johnson & Johnson's industry-leading portfolio. The Company will continue to prioritize innovation and building new capabilities to improve the lives of the patients and consumers we serve worldwide.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Avricore Health

Healthtab™ Expands With Shoppers Drug Mart®

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased to announce that the Company is significantly expanding the number of Shoppers Drug Mart pharmacies offering its HealthTab point-of-care testing platform under a renewed Master Service Agreement (MSA) to up to 450 locations nation-wide.

In addition to Shoppers Drug Mart pharmacies, this new MSA and corresponding Statement of Work (SOW) provides for affiliated locations under the Loblaw family of brands, to utilize HealthTab upon request.

Keep reading...Show less

Abbott and WeightWatchers Partner to Support People Living with Diabetes in Attaining their Health Goals

  • Two industry leaders join forces to empower people living with diabetes by providing information and insights to improve weight loss, glucose control and overall health
  • Collaboration will create a seamless, integrated experience between Abbott's world-leading continuous glucose monitoring device 1 and WeightWatchers' number one doctor-recommended weight loss program 2 to help individuals better understand and manage their diabetes and weight

Abbott (NYSE: ABT) and WW International, Inc. ("WeightWatchers" or "WW") today announced a strategic partnership that will help people living with diabetes better understand and manage their diabetes and weight. The companies are working together to integrate WeightWatchers' diabetes-tailored weight management program with Abbott's portfolio of FreeStyle Libre ® products to create a seamless mobile experience that will give people living with diabetes the information and insights needed to make healthy adjustments to their diet, improve their glucose levels, and, ultimately, gain more control of their health.

Maintaining a healthy body weight and having proper nutrition are critical to living well with diabetes. 3 Yet, for many people living with diabetes, determining what to eat and following a meal plan is the most challenging part of diabetes management. 4 Through this partnership, participants can receive glucose insights from Abbott's FreeStyle Libre sensor-based technology that show the impact of food choices, alongside the empirically validated 5 WeightWatchers' diabetes-tailored nutritional guidance to help them achieve their healthier living goals.

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

Notice of Knight Therapeutics' Second Quarter 2022 Results Conference Call

Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its second quarter 2022 financial results on Thursday, August 11, 2022 prior to market opening. Following the release, Knight will hold a conference call and audio webcast. Knight cordially invites all interested parties to participate in this call.

Date : Thursday, August 11, 2022

Time : 8:30 a.m. ET

Telephone : Toll Free: 1-855-669-9657 or International 1-412-317-0790

Webcast : www.gud- knight .com or Webcast
This is a listen-only audio webcast. Media Player is required to listen to the broadcast.

Replay : An archived replay will be available for 30 days at .

About Knight Therapeutics Inc.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News